$MS US Morgan Stanley ranked positive on Nov 17th 2020

Hutham Olayan (Director since 2006) purchased 25,000 shares on November 12th at $55.40, spending $1.4m and increasing her holdings to 218,478 shares. This is Olayan’s third open market buy since joining the board 14 years ago and is by far her largest. Her last purchase was in 2011 at $20. We were also intrigued to […]

Read More

$DNB Dun & Bradstreet ranked positive on Nov 10th 2020

Anthony Jabbour (CEO since 2020) purchased $1 million of stock on the 6th of November at $26.31. This is his first purchase since the IPO in July 2020 when he subscribed for $4.4 million at $22. He only made 3 purchases when CEO at Black Knight but they were well-timed. Bryan Hipsher (CFO since 2020) […]

Read More

$PTVI US Pactiv Evergreen ranked positive on Nov 25th 2020

After seeing a cluster of four directors, the Chairman, a Divisional President, the CEO and CFO all buy shares on September 21st, one of the buyers, Allen Hugli (Director) has made an additional purchase spending $160,000 at $15.97. This is a solid show of confidence from board members and officers, and a mixture of buying […]

Read More

Why didn’t we negatively rank Pfizer $PFE US on the recent CEO Share sale?

Albert Bourla’s sale of $5.5m of stock on the announcement of Pfizer’s Covid-19 vaccine success generated significant headlines as it represented 62% of his equity holding. When ranking stocks a key point we look at is the sale relative to their total holding. In the US executives typically have options that are exercisable to become […]

Read More

$RTX Raytheon Technologies ranked positive on Nov 2nd 2020

Gregory Hayes (CEO since 2020, first joined 2003) purchased $3 million of stock on the 28th Oct at US$54.82. This is his first ever purchase and he has been a regular seller, crystalising approx $24 million through option sales (net of the option cost). Thomas Kennedy (Chairman since 2020, previously CEO of Raytheon from 2016 […]

Read More